<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>math.GN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/math.GN</link>
    <description>math.GN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/math.GN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Fri, 07 Mar 2025 05:00:04 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Fri, 07 Mar 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Sunday</day>
      <day>Saturday</day>
    </skipDays>
    <item>
      <title>Topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction</title>
      <link>https://arxiv.org/abs/2407.08974</link>
      <description>arXiv:2407.08974v3 Announce Type: replace-cross 
Abstract: Recently, therapeutic peptides have demonstrated great promise for cancer treatment. To explore powerful anticancer peptides, artificial intelligence (AI)-based approaches have been developed to systematically screen potential candidates. However, the lack of efficient featurization of peptides has become a bottleneck for these machine-learning models. In this paper, we propose a topology-enhanced machine learning model (Top-ML) for anticancer peptides prediction. Our Top-ML employs peptide topological features derived from its sequence "connection" information characterized by vector and spectral descriptors. Our Top-ML model, employing an Extra-Trees classifier, has been validated on the AntiCP 2.0 and mACPpred 2.0 benchmark datasets, achieving state-of-the-art performance or results comparable to existing deep learning models, while providing greater interpretability. Our results highlight the potential of leveraging novel topology-based featurization to accelerate the identification of anticancer peptides.</description>
      <guid isPermaLink="false">oai:arXiv.org:2407.08974v3</guid>
      <category>q-bio.QM</category>
      <category>cs.LG</category>
      <category>math.GN</category>
      <category>q-bio.BM</category>
      <pubDate>Fri, 07 Mar 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>replace-cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Joshua Zhi En Tan, JunJie Wee, Xue Gong, Kelin Xia</dc:creator>
    </item>
  </channel>
</rss>
